Our in vitro and in vivo experiments thus far indicated that TMEM52B‐P20 promotes NPC cell motility and metastasis more effectively than TMEM52B‐P18, prompting us to investigate the underlying mechanisms. Here, TMEM52B is linked to nasopharyngeal carcinoma.